0.7351
price up icon1.67%   0.0121
after-market Dopo l'orario di chiusura: .75 0.0149 +2.03%
loading

Invivyd Inc Borsa (IVVD) Ultime notizie

pulisher
Jun 16, 2025

Trading Day Triumph: Invivyd Inc (IVVD) Ends at 0.79, a -6.47 Surge/Plunge - DWinneX

Jun 16, 2025
pulisher
May 29, 2025

H.C. Wainwright Lowers Invivyd (IVVD) PT to $5 Amid Q1 2025 Revenue Shortfall - Insider Monkey

May 29, 2025
pulisher
May 29, 2025

Invivyd stock target cut to $5 by H.C. Wainwright, retains Buy rating - Investing.com Nigeria

May 29, 2025
pulisher
May 29, 2025

Invivyd (NASDAQ:IVVD) Price Target Lowered to $5.00 at HC Wainwright - Defense World

May 29, 2025
pulisher
May 28, 2025

Invivyd (IVVD) Analyst Rating Update: Price Target Lowered | IVV - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Invivyd (IVVD) Price Target Reduced by H.C. Wainwright Amid Revenue Concerns | IVVD Stock News - GuruFocus

May 28, 2025
pulisher
May 27, 2025

Invivyd (IVVD) Publishes Strong Phase 3 Trial Results for COVID-19 Antibody | IVVD Stock News - GuruFocus

May 27, 2025
pulisher
May 27, 2025

Invivyd Announces Publication of Landmark CANOPY Phase 3 PEMGARDA® (pemivibart) Clinical Trial; Results Underscore Strong Efficacy of Monoclonal Antibodies in Preventing COVID-19 in a Modern U.S. Population Against Relevant, Immune-Evasive S - The Manila Times

May 27, 2025
pulisher
May 27, 2025

Breakthrough COVID-19 Drug PEMGARDA Achieves 84% Protection in First Modern U.S. Phase 3 Trial - Stock Titan

May 27, 2025
pulisher
May 23, 2025

Invivyd’s antibody gains spot in cancer guidelines for COVID-19 PrEP By Investing.com - Investing.com South Africa

May 23, 2025
pulisher
May 23, 2025

Invivyd’s antibody gains spot in cancer guidelines for COVID-19 PrEP - Investing.com Australia

May 23, 2025
pulisher
May 23, 2025

Invivyd's Pemgarda Added to NCCN Guidelines in Oncology for B-Cell Lymphomas - marketscreener.com

May 23, 2025
pulisher
May 23, 2025

Invivyd Announces Inclusion of PEMGARDA® (pemivibart) in National Comprehensive Cancer Network® (NCCN®) Clinical Practice Guidelines in Oncology for B-Cell Lymphomas - The Manila Times

May 23, 2025
pulisher
May 23, 2025

Invivyd (IVVD) Monoclonal Antibody Added to NCCN Guidelines for B-Cell Lymphomas | IVVD Stock News - GuruFocus

May 23, 2025
pulisher
May 23, 2025

NCCN Guidelines Now Include PEMGARDA for B-Cell Lymphoma COVID Protection | IVVD Stock News - Stock Titan

May 23, 2025
pulisher
May 21, 2025

Invivyd (IVVD) Applauds FDA's Steps to Address COVID-19 Booster Uncertainty | IVVD Stock News - GuruFocus

May 21, 2025
pulisher
May 21, 2025

Invivyd Commends FDA Focus on Contemporary Evidence In Evaluating Medical Interventions To Prevent COVID-19 - The Manila Times

May 21, 2025
pulisher
May 21, 2025

Invivyd Commends FDA on New Framework for COVID-19 Vaccines Amidst Uncertainty Regarding Booster Efficacy - Nasdaq

May 21, 2025
pulisher
May 21, 2025

FDA Questions COVID Booster Benefits While Invivyd's Antibody Shows 84% Protection in Modern Trials - Stock Titan

May 21, 2025
pulisher
May 20, 2025

Invivyd at H.C. Wainwright Conference: Strategic Moves in Antibodies By Investing.com - Investing.com Nigeria

May 20, 2025
pulisher
May 20, 2025

Invivyd Holds Annual Stockholders Meeting, Elects Directors - TipRanks

May 20, 2025
pulisher
May 20, 2025

Invivyd at H.C. Wainwright Conference: Strategic Moves in Antibodies - Investing.com

May 20, 2025
pulisher
May 20, 2025

Upstream Bio Strengthens Leadership Team: Former Invivyd Executive Takes CTO Role for Critical Clinical Program - Stock Titan

May 20, 2025
pulisher
May 17, 2025

Invivyd, Inc. (IVVD) Reports Q1 Loss, Lags Revenue Estimates - MSN

May 17, 2025
pulisher
May 16, 2025

Invivyd (IVVD) Maintains Buy Rating with Stable Price Target | I - GuruFocus

May 16, 2025
pulisher
May 16, 2025

Invivyd, Inc. (NASDAQ:IVVD) Q1 2025 Earnings Call Transcript - Insider Monkey

May 16, 2025
pulisher
May 16, 2025

Invivyd Q1 2025 slides: Revenue grows amid regulatory hurdles and cash concerns - Investing.com Nigeria

May 16, 2025
pulisher
May 16, 2025

Invivyd (IVVD) Maintains Buy Rating with Stable Price Target | IVVD Stock News - GuruFocus

May 16, 2025
pulisher
May 16, 2025

Earnings call transcript: Invivyd Q1 2025 sees stock drop amid earnings miss - Investing.com Canada

May 16, 2025
pulisher
May 16, 2025

Earnings call transcript: Invivyd Q1 2025 sees stock drop amid earnings miss By Investing.com - Investing.com South Africa

May 16, 2025
pulisher
May 16, 2025

Invivyd Reports Q1 2025 Financial Results and Outlook - TipRanks

May 16, 2025
pulisher
May 15, 2025

Invivyd’s Earnings Call: Strategic Moves Amid Challenges - TipRanks

May 15, 2025
pulisher
May 15, 2025

Why JD.com Stock Slumped on Thursday - The Globe and Mail

May 15, 2025
pulisher
May 15, 2025

INVIVYD SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Invivyd, Inc.IVVD, A - Barchart.com

May 15, 2025
pulisher
May 15, 2025

Transcript : Invivyd, Inc., Q1 2025 Earnings Call, May 15, 2025 - marketscreener.com

May 15, 2025
pulisher
May 15, 2025

Invivyd (IVVD) Reports Q1 Revenue Below Expectations Amid Strate - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Invivyd (IVVD) Reports Q1 Revenue Below Expectations Amid Strategic Shift | IVVD Stock News - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Invivyd Reports Q1 2025 Financial Results and Highlights - TipRanks

May 15, 2025
pulisher
May 15, 2025

INVIVYD Earnings Results: $IVVD Reports Quarterly Earnings - Nasdaq

May 15, 2025
pulisher
May 15, 2025

Invivyd, Inc. SEC 10-Q Report - TradingView

May 15, 2025
pulisher
May 15, 2025

Invivyd Reports First Quarter 2025 Financial Results and Recent Business Highlights - The Manila Times

May 15, 2025
pulisher
May 15, 2025

Invivyd, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com

May 15, 2025
pulisher
May 15, 2025

Invivyd calls for modernized FDA vaccine guidelines By Investing.com - Investing.com Canada

May 15, 2025
pulisher
May 14, 2025

Invivyd Launches New Measles Antibody Discovery Program: Retail Traders Bet On ‘Future Of Medicine’ - MSN

May 14, 2025
pulisher
May 14, 2025

What To Expect From Invivyd Inc (IVVD) Q1 2025 Earnings - Yahoo Finance

May 14, 2025
$20.30
price down icon 0.68%
$36.37
price up icon 0.50%
$24.55
price up icon 8.53%
$97.80
price down icon 0.45%
$110.00
price up icon 1.61%
biotechnology ONC
$245.49
price up icon 0.48%
Capitalizzazione:     |  Volume (24 ore):